<div id="readability-page-1"><p><span>Oracle (NYSE:ORCL - Get Free Report)</span> had its price target lifted by equities research analysts at Morgan Stanley  from $246.00 to $320.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an &#34;equal weight&#34; rating on the enterprise software provider's stock. Morgan Stanley's price objective would suggest a potential upside of 1.64% from the company's previous close.</p><ul><li>Bloom Energy Booms on AI Power Demand and Analyst Upgrades</li></ul><p>Other equities analysts also recently issued reports about the company. TD Cowen boosted their price objective on Oracle from $325.00 to $375.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, September 10th. BNP Paribas  set a $377.00 price objective on Oracle in a research report on Wednesday, September 10th. Cantor Fitzgerald increased their price objective on shares of Oracle from $271.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, September 10th. DA Davidson increased their price objective on shares of Oracle from $220.00 to $300.00 and gave the company a &#34;neutral&#34; rating in a report on Wednesday, September 10th. Finally, Royal Bank Of Canada increased their price objective on shares of Oracle from $145.00 to $195.00 and gave the company a &#34;sector perform&#34; rating in a report on Thursday, June 12th. Two analysts have rated the stock with a Strong Buy rating, twenty-five have assigned  a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $305.75.</p><p><b>Check Out Our Latest Research Report on Oracle</b></p><h2>Oracle Stock Down 4.1%</h2><ul><li>Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why</li></ul><p>Shares of ORCL stock traded down $13.32 during trading hours on Tuesday, hitting $314.83. 17,436,550 shares of the company's stock traded hands, compared to its average volume of 14,177,963. The stock's fifty day simple moving average is $253.63 and its two-hundred day simple moving average is $196.92. Oracle has a 12-month low of $118.86 and a 12-month high of $345.72. The stock has a market cap of $894.65 billion, a price-to-earnings ratio of 72.92, a PEG ratio of 3.34 and a beta of 1.46. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. </p><p>Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm had revenue of $14.93 billion during the quarter, compared to analysts' expectations of $15.04 billion. During the same quarter in the previous year, the firm earned $1.39 earnings per share. Oracle's revenue was up 12.2% on a year-over-year basis.  Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, analysts expect that  Oracle will post 5 EPS for the current year. </p><h2>Insider Buying and Selling at Oracle</h2><ul><li>Meta Slips as Oracle Surges: ORCL's AI Outlook Bearish for Meta?</li></ul><p>In related news, Director Naomi O. Seligman sold 3,303 shares of the business's stock in a transaction that occurred on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total value of $770,655.96. Following the completion of the sale, the director directly owned 31,447 shares in the company, valued at approximately $7,337,214.04. The trade was a 9.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, insider Michael D. Sicilia sold 16,323 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $313.60, for a total transaction of $5,118,892.80. Following the sale, the insider owned 110,094 shares of the company's stock, valued at approximately $34,525,478.40. This represents a 12.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,247 shares of company stock valued at $22,090,505. Corporate insiders own  42.20% of the company's stock. </p><h2>Institutional Inflows and Outflows</h2><p>A number of institutional investors have recently made changes to their positions in ORCL. Vanguard Group Inc. raised its holdings in  Oracle by 2.1% in the second quarter. Vanguard Group Inc. now owns 164,278,874 shares of the enterprise software provider's stock valued at $35,916,290,000 after acquiring an additional 3,353,461 shares in the last quarter.  State Street Corp raised its holdings in  Oracle by 1.7% in the second quarter. State Street Corp now owns 73,459,391 shares of the enterprise software provider's stock valued at $16,060,427,000 after acquiring an additional 1,252,723 shares in the last quarter.  Northern Trust Corp increased its stake in  Oracle by 0.6% during the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider's stock valued at $2,760,048,000 after purchasing an additional 120,889 shares during the last quarter.  Norges Bank bought a new stake in  Oracle during the second quarter valued at $4,275,378,000.  Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in  Oracle by 0.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider's stock valued at $1,941,195,000 after purchasing an additional 59,164 shares during the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds. </p><h2>About Oracle</h2> (Get Free Report)<p>Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.</p><h2>See Also</h2><ul><li>Five stocks we like better than Oracle</li><li>Consumer Staples Stocks, Explained</li><li>Is Super Micro Next in Line for a Big AI Takeover?</li><li>High Dividend REITs: Are They an Ideal Way to Diversify?</li><li>Tesla: 3 Reasons October’s Earnings Will Make or Break the Stock</li><li>Value Investing: Is it a Good Strategy in 2022? <span>Hint: Always<span></span></span></li><li>Industrial Tech Crossovers: When Manufacturing Meets Innovation</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oracle Right Now?</h2><p>Before you consider Oracle, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.</p><p>While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ORCL

<p>Morgan Stanley has raised its price target for Oracle (NYSE:ORCL) from $246.00 to $320.00, maintaining an "equal weight" rating. This suggests a potential upside of 1.64% from the previous close. Other analysts have also increased their price targets, with a consensus rating of "Moderate Buy" and an average target of $305.75. Despite the positive outlook, Oracle's stock fell 4.1% to $314.83 during trading. The company reported earnings of $1.47 per share, slightly missing estimates, with revenue up 12.2% year-over-year.</p>

Oracle (NYSE:ORCL) Given New $320.00 Price Target at Morgan Stanley